Brief: Sprint Bioscience: Petra Pharma Applies For Three Patents For PIP4K2
Jan 23 (Reuters) - SPRINT BIOSCIENCE AB SPRINT.ST :
* PETRA PHARMA CORPORATION APPLIES FOR THREE PATENTS FOR
CANCER
PROJECT PIP4K2
Source text for Eikon: ID:nWkr6g7K24
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program